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Lys-derived alkaloids, including piperidine, quinolizidine, indolizidine, and lycopodium alka-
loids, are widely distributed throughout the plant kingdom. Several of these alkaloids have
beneﬁcial properties for humans and have been used in medicine. However, the molecular
mechanisms underlying the biosynthesis of these alkaloids are not well understood. In the
present article, we discuss recent advances in our understanding of Lys-derived alkaloids,
especially the biochemistry, molecular biology, and biotechnology of quinolizidine alkaloid
(QA) biosynthesis. We have also highlighted Lys decarboxylase (LDC), the enzyme that
catalyzes the ﬁrst committed step of QA biosynthesis and answers a longstanding ques-
tion about the molecular entity of LDC activity in plants. Further prospects using current
advanced technologies, such as next-generation sequencing, in medicinal plants have also
been discussed.
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INTRODUCTION
Plant secondary metabolites play multiple roles in the interac-
tion between plants and their environment (Dixon, 2001). Almost
100,000 secondary metabolites have been discovered from plant
species (Verpoorte, 1998; Hostettmann andTerreaux, 2000; Afendi
et al., 2012). Alkaloids are organic nitrogenous bases, usually in a
heterocyclic ring, with characteristic toxicity and marked phar-
macological effects in humans and animals (De Luca and St
Pierre, 2000). Alkaloids are derived from the products of primary
metabolism, with amino acids, such as Phe, Tyr, Trp, Orn, and Lys,
serving as their main precursors (Facchini, 2001). Approximately
20% of plant species accumulate alkaloids and over 12,000 differ-
ent alkaloids have been described, suggesting higher structural and
biosynthetic diversity compared to other secondary metabolites
(Croteau et al., 2000; De Luca and St Pierre, 2000).
Alkaloids derived from Lys are widely distributed through-
out the plant kingdom and are subdivided into piperidine,
quinolizidine, indolizidine, and lycopodium alkaloids. Piperidine
alkaloids are found in plants in the order Piperales (e.g., piperine
from Piper nigrum), Myrtales (e.g., (−)-pelletierine from Punica
granatum), and Asterales (e.g., (−)-lobeline from Lobelia inﬂata).
Quinolizidine (e.g., (−)-lupinine and (−)-sparteine from Lupinus
luteus and Cytisus scoparius, respectively) and indolizidine (e.g.,
(−)-swainsonine from Swainsona canescens) alkaloids are found
mainly in the order Fabales (Murakoshi et al., 1975, 1986; Cole-
gate et al., 1979; Su and Horvat, 1981; Neuhofer et al., 1993; Felpin
and Lebreton, 2004). Lycopodium alkaloids (e.g., (−)-huperzine
A and lycopodine from Huperzia serrata) are found mainly in
the genus Lycopodium (Figure 1; Liu et al., 1986; Ma and Gang,
2004). Several alkaloids have beneﬁcial properties for humans and
are used in medicine. For example, (−)-lobeline is used in the
treatment of central nervous system disorders and drug abuse and
(−)-huperzine A is used in the treatment of Alzheimer’s disease
(Decker et al., 1992; Bai et al., 2000; Dwoskin et al., 2000; Dwoskin
and Crooks, 2002).
Over the past decade, intensive efforts have been made to iden-
tify the genes encoding the enzymes involved in the biosynthesis of
isoquinoline, indole, tropane, and purine alkaloids (Croteau et al.,
2000; Facchini et al., 2004). However, the molecular mechanisms
underlying the biosynthesis of Lys-derived alkaloids are poorly
understood. In this article, we discuss recent advances in our
understanding of the Lys-derived alkaloids, especially the genes
involved in the quinolizidine alkaloid (QA) biosynthetic path-
way. We highlight the novel ﬁnding of Lys decarboxylase (LDC)
from plants and discuss how it evolved from primary metabolism
to alkaloid biosynthesis. Finally, we consider how to apply cur-
rent advanced technologies to the study of unidentiﬁed alkaloid
biosynthetic pathways.
BIOSYNTHESIS OF LYS-DERIVED ALKALOIDS
L-Lys is the homologue of L-Orn, a precursor of pyrrolidine,
tropane, and pyrrolizidine alkaloids. The extra methylene group
in Lys participates in forming 6-membered piperidine rings,
whileOrn participates in forming 5-membered pyrrolizidine rings
(Dewick, 2001; Poupon et al., 2011). Biosynthetic pathways of sev-
eral potential Lys-derived alkaloids have been proposed based on
tracer experiments with labeled precursors (Leistner and Spenser,
1973 and references therein). Feeding studies demonstrated that
the ﬁrst step in piperidine, quinolizidine, and lycopodium alka-
loid biosynthesis is the decarboxylation of L-Lys into cadaverine by
LDC (EC 4.1.1.18). Oxidative deamination of cadaverine by cop-
per amine oxidase (CuAO, EC 1.4.3.22) yields 5-aminopentanal,
which is spontaneously cyclized to Δ1-piperideine Schiff base
(Leistner and Spenser, 1973; Gupta et al., 1979; Golebiewski and
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FIGURE 1 | Biosynthesis of universal intermediates, skeleton structures,
and some Lys-derived alkaloids found in plants. Piperine, (−)-pelletierine,
and (−)-lobeline are piperidine alkaloids. (−)-Lupinine and (−)-sparteine are
quinolizidine alkaloids. (−)-Swainsonine is an indolizine alkaloids. Lycopodine
and (−)-huperzine A are lycopodium alkaloids. LDC, Lys decarboxylase; CuAO,
copper amine oxidase.
Spenser, 1988; Saito and Murakoshi, 1995; Ma and Gang, 2004).
In contrast, indolizidine alkaloids are formed from L-Lys via L-
pipecolic acid which is formed via the aldehyde and Schiff base,
with retentionof the nitrogenof theα-amino acid group (Figure 1;
Harris et al., 1988a,b; Wickwire et al., 1990; Dewick, 2001). Δ1-
Piperideine and L-pipecolic acid are universal intermediates that
can be modiﬁed by condensation, hydrolysis, or methylation to
produce diverse Lys-derived alkaloids (Figure 1; Evans, 2009).
The genes and enzymes involved in the biosynthesis of Lys-
derived alkaloids are not well documented. The best-studied
pathway at the genetic level is the one leading to the formation
of QAs, which will be discussed in the following section. One
other study addresses partially puriﬁed piperoyl-CoA: piperidine
N-piperoyltransferase (EC 2.3.1.145) from P. nigrum which cat-
alyzes the synthesis of piperine in the presence of piperoyl-CoA
and piperidine (Geisler and Gross, 1990).
QUINOLIZIDINE ALKALOIDS
Quinolizidine alkaloids are a group of alkaloids possessing a
quinolizidine ring or a piperidine ring (Saito and Murakoshi,
1995). QAs occur mainly in the family Leguminosae, especially
in the genera Lupinus, Baptisia, Thermopsis, Genista, Cytisus, and
Sophora (Ohmiya et al., 1995). More than 500 Lupinus species
have been described and 200–300 species are distributed in North
and South America (Wink et al., 1995). QAs are important as
potential sources of medicine. They have a broad range of phar-
macological properties, including cytotoxic, oxytocic, antipyretic,
antibacterial, antiviral, and hypoglycemic activities, as determined
by in vivo pharmacological screening (Saito andMurakoshi, 1995).
Some QA-containing plants, for example Sophora ﬂavescens, have
been used as sources of crude drugs in Chinese–Japanesemedicine
(KAMPO; Tang and Eisenbrand, 1992).
Quinolizidine alkaloids are synthesized through the cycliza-
tion of the cadaverine unit (Golebiewski and Spenser, 1988),
which is produced through the action of LDC (Figure 2; Saito
and Murakoshi, 1995). Various QA skeletons are further mod-
iﬁed by tailoring reactions (e.g., dehydrogenation, oxygenation,
or esteriﬁcation) to yield several hundred structurally related
alkaloids (Ohmiya et al., 1995). Lupinus accumulates two types
of QA esters, the derivatives of lupinine and lupanine. QA
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FIGURE 2 | Biosynthetic pathway of quinolizidine alkaloids. Quinolizidine
alkaloids are synthesized by the decarboxylation of Lys, yielding cadaverine,
which is further modiﬁed by various reactions as shown. The metabolites
derived from the pathway are shown. Enzymes involved in the synthesis of
these alkaloids are indicated: LDC, Lys decarboxylase; HMT/HLT, tigloyl-CoA:
(−)-13α-hydroxymultiﬂorine/(+)-13α-hydroxylupanine O-tigloyltransferase;
ECT/EFT-LCT/LFT, p-coumaroyl-CoA/feruloyl-CoA: (+)-epilupinine/(−)-lupinine
O-coumaroyl/feruloyltransferase.
esters are assumed to be end products of biosynthesis and stor-
age forms (Ohmiya et al., 1995). Two acyltransferases (ATs)
involved in QA ester biosynthesis have been identiﬁed and charac-
terized: (−)-13α-hydroxymultiﬂorine/(+)-13α-hydroxylupanine
O-tigloyltransferase (HMT/HLT; EC 2.3.1.93), which cat-
alyzes the transfer of the tigloyl group from tigloyl-CoA to
(−)-13α-hydroxymultiﬂorine or (+)-13α-hydroxylupanine, and
p-coumaroyl-CoA/feruloyl-CoA: (+)-epilupinine/(−)-lupinine
O-coumaroyl/feruloyltransferase (ECT/EFT-LCT/LFT), which
catalyzes the transfer of p-coumaroyl-CoA or feruloyl-CoA to the
hydroxyl moiety of (+)-epilupinine or (−)-lupinine (Figure 2;
Saito et al., 1992, 1993; Suzuki et al., 1994). However, only
HMT/HLT has been cloned and characterized at the molecular
level (Okada et al., 2005). HMT/HLT belongs to the BAHD super
family, a plant acyl-CoA-dependent AT gene family that transfers
acyl groups from their CoA esters to various plant metabolites
(D’Auria, 2006).
An investigation of an alkaloid-rich “bitter” cultivar and an
alkaloid-poor “sweet” cultivar of L. angustifolius using random
ampliﬁed polymorphic DNA (RAPD) showed that total DNA
polymorphisms did not differ substantially between the two cul-
tivars (Hirai et al., 2000). A cDNA-ampliﬁed fragment length
polymorphism (cDNA-AFLP) was then used to isolate the genes
speciﬁcally expressed in the bitter plant; however, no bitter-speciﬁc
gene was isolated (Hirai et al., 2000). The PCR-select subtraction
technique was then used to proﬁle differentially expressed genes in
the two cultivars. Among 71 bitter-speciﬁc fragments, three genes
exhibited homologies to Orn decarboxylase (ODC, EC 4.1.1.17),
CuAO, and AT, representing potential candidates for structural
genes encoding QA biosynthetic enzymes (Bunsupa et al., 2011).
Further study showed that the AT might be involved either in
the formation of QA esters or N-acylated polyamine conjugates
(Bunsupa et al., 2011) and ODC was identiﬁed as Lys/Orn decar-
boxylase (L/ODC; see below) (Bunsupa et al., 2012). In addition,
partial sequences encoding candidate transcription factors that
might regulate the expression of genes in QA biosynthesis were
obtained; these included DNA binding protein EREBP-3, leucine
zipper protein, and coronatine-insensitive 1, which provide clues
about the regulation of the QA biosynthetic pathway (Bunsupa
et al., 2011). Genomic PCR of L. angustifolius AT and LDC indi-
cated the presence of at least one copy of both genes in the genomes
of both the bitter and sweet cultivars. However, transcripts of both
genes were expressed only in the bitter cultivar. This ﬁnding is
interesting in terms of the regulation of the entire QA biosynthetic
pathway (Bunsupa et al., 2011, 2012).
A NOVEL LYS DECARBOXYLASE FROM QUINOLIZIDINE
ALKALOIDS PRODUCING PLANTS
Lys decarboxylase and ODC are key enzymes involved in the for-
mation of cadaverine and putrescine by the decarboxylation of Lys
and Orn, respectively. Cadaverine, putrescine, and other aliphatic
polyamines, such as spermidine and spermine, are involved in a
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number of growth and developmental processes (Bagni and Tas-
soni, 2001). Unlike plant ODCs, plant LDCs have not been well
studied at the molecular level. There are several studies on crude
protein extracts or partially puriﬁed protein extracts from Glycine
max (Kim et al., 1998; Ohe et al., 2009) and L. polyphyllus (Hart-
mann et al., 1980). There was speculation that a member of group
IV of the PLP-dependent amino acid decarboxylases might be
responsible for the production of cadaverine from Lys (Sandmeier
et al., 1994) and that ODC may also have LDC activity in plants
that make cadaverine-derived alkaloids (Sinclair et al., 2004).
Recently, we isolated a cDNA of L/ODC from L. angus-
tifolius (La-L/ODC) using differential transcript screening in
QA-producing and non-producing cultivars (Bunsupa et al., 2011,
2012). We also obtained L/ODCs cDNAs from S. ﬂavescens and
Echinosophora koreensis, which also produce QAs. Recombinant
L/ODCs from QA-producing plants almost equally catalyzed the
decarboxylation of L-Lys and L-Orn unlike the known ODCs
that only accept Orn (Boeker and Fischer, 1983; Bunsupa et al.,
2012). In vivo experiments of La-L/ODC expression in Arabidop-
sis thaliana and Nicotiana tabacum provided evidence that this
enzyme is involved in the ﬁrst step of QA biosynthesis (Bunsupa
et al., 2012). This is the ﬁrst plant LDC identiﬁed at the molecular
level by cDNA cloning and the second QA biosynthesis enzyme
for which the cDNA has been identiﬁed.
Identiﬁcation of La-L/ODC answers a longstanding question
about the molecular entity of LDC activity in plants. We found
LDCs in plant species that produce QAs. A point mutation from
His-344 to Phe-344 (La-L/ODC numbering) is key for La-L/ODC
to exhibit substrate promiscuity for Lys and Orn. This amino acid
substitution has presumably occurred via adaptive evolution of
LDC within the QA-producing plants to expand substrate accessi-
bility to Lys (Bunsupa et al., 2012). These results reveal how plants
have been opportunistic in adapting primary metabolic processes
to permit the diversiﬁcation of secondary metabolism, in this case,
substrate promiscuity. Accordingly, the mutation in this position
may be found not only in QA-producing Leguminosae but also in
plants that produce cadaverine-derived alkaloids. This ﬁnding is a
breakthrough in the understanding of both QA biosynthesis and
LDC occurrence and function in plants.
A major safety issue of lupine-based foods is the presence of
QAs,which are toxic to human andmammals. Geneticmapping of
L. angustifolius and L. albus has been completed, which enables the
mapping of the genes controlling key domestication traits, includ-
ing alkaloid production, water permeability, ﬂowering time, pod
shattering, pigment production in seeds, and anthracnose resis-
tance (Boersma et al., 2005; Nelson et al., 2006; Phan et al., 2006).
This information will be useful not only to the Lupinus research
community but also to other legume research communities study-
ing molecular breeding and evolution in leguminous plants. The
identiﬁed La-L/ODC provides a good candidate enzyme as an
entry-point enzyme of QA biosynthesis for metabolic engineering
to manipulate the production of QAs.
COMPARTMENTALIZATION AND SUBCELLULAR
LOCALIZATION
The subcellular compartmentalization of alkaloid biosynthetic
enzymes is as complex as the cell type-speciﬁc localization of
gene transcripts, enzymes, and metabolites (Ziegler and Facchini,
2008). The majority of QAs are synthesized in shoot tissues. Of
the QAs that accumulate in seeds, half are synthesized in situ and
half are translocated primarily by phloem (Lee et al., 2007). The
concentration of QAs in seeds decreases during germination and
development and increases as soon as new leaves are formed (Wink
and Witte, 1985). The biosynthesis of QAs occurs mainly in the
green parts of plants where the enzymes for Lys, cadaverine, and
lupanine synthesis are present (Wink and Hartmann, 1979, 1982;
Wink and Mende, 1987). La-L/ODC is localized in chloroplasts,
while HMT/HLT localized in mitochondria. ECT is assumed to
be present in another organelle, but not in mitochondria (Suzuki
et al., 1996; Bunsupa et al., 2012).
ENGINEERING IN QA-PRODUCING PLANTS
The concentration of QAs in cell suspension cultures of Lupinus
and related plants is approximately 100–1000 times lower than
that of concentration in leaves of differentiated plants (Hartmann
et al., 1980; Hernandez et al., 2011). In cell suspension cultures,
the storage tissue is probably repressed; thus, the QAs cannot be
stored in large quantities and are degraded rapidly either inside
the cells or in the cell culture medium (Wink, 1987). In callus, the
concentration of QAs is correlated to the amount of chlorophyll
in the cells (Saito et al., 1989a,b).
Lupinus spp. are the major grain legumes in Australia and have
been used as feed supplements. In the past decade, they have
gained attention as ingredients for human food because of their
high percentage of protein (34–43% of dry matter) and acceptable
content of essential amino acids (Sujak et al., 2006). To genetically
engineer plants successfully, a routine transformation system is
needed. Thus, it is necessary to develop a transformation system
for Lupinus lines to confer desired traits, such as herbicide resis-
tance, resistance to certain pathogens, increased pod and seed set,
and improved seed quality (Pigeaire et al., 1997). Many transfor-
mation systems forLupinus sp. have beendeveloped; however, only
a few have been successful. For example, shoot regeneration using
Agrobacterium-mediated gene transfer to preorganized meristem-
atic tissue combinedwith axillary regeneration has been successful
in L. angustifolius (Pigeaire et al., 1997), L. luteus (Li et al., 2000),
and L. mutabilis (Babaoglu et al., 2000). However, transformation
efﬁciency is poor and transformation in some Lupinus species
and even in different cultivars of the same species is difﬁcult. In
L. mutabilis, the transformed roots synthesize isoﬂavones, but not
QAs (Babaoglu et al., 2004). Genetic engineering of L. angustifolius
by over expressed sun ﬂower seed albumin gene has succeeded to
enhance methionine levels and increase nutritive value of seeds of
transgenic Lupinus plants (Molvig et al., 1997).
FUTURE PROSPECTS
In the past few years, progress has been made in the elucidation of
alkaloid biosynthetic pathways and their regulation. However, only
two genes, HMT/HLT and L/ODC, have been isolated and char-
acterized so far. Rapid progress in the development of integrative
approaches, such as genomics, transcriptomics, proteomics, and
metabolomics, has provided essential information for the under-
standing of many complex biological processes at different levels
(Fukushima et al., 2009; Yonekura-Sakakibara and Saito, 2009).
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Comparative and integrative analyses of such “omics” data will
facilitate thedeterminationof gene function andpinpoint rate lim-
iting steps and factors in the biosynthetic pathway of secondary
metabolites. Transcriptomic and metabolomic approaches, par-
ticularly transcriptome coexpression network analysis, have been
used to identify genes involved in speciﬁc pathways not only in
Arabidopsis but also in crops and medicinal plants. Such strategies
have proven to be useful in fundamental plant biology and applied
biotechnology (Ziegler et al., 2006; Hirai et al., 2007; Saito et al.,
2008: Seki et al., 2008; Yonekura-Sakakibara et al., 2008, 2012; Lis-
combe et al., 2009; Okazaki et al., 2009; Saito and Matsuda, 2010;
Okazaki and Saito, 2012).
Advances in sequencing technology, next-generation sequenc-
ing, and computer technology for processing of large data sets
are opening a new era in plant science. It is estimated that the
cost of DNA sequencing drops at a faster rate than the cost
of computer data processing (Ehrhardt and Frommer, 2012).
Therefore, the development of sequencing techniques with high-
throughput will likely be applied to alkaloid-producing plants
and provide the basis for many sequence-based approaches
that are now limited to model plants such as Arabidopsis and
rice (Ziegler and Facchini, 2008). Today, many researchers are
making progress in plant genome and transcriptome sequenc-
ing. For instance, the 1KP project aims to generate large-scale
gene sequence information for 1000 different plants, includ-
ing a wide variety of species from algae to land and aquatic
plants, to understand the vast biodiversity that has barely been
touched by genomics to date1. In addition, the medicinal plant
consortium project focuses on providing transcriptomic and
metabolic resources for 14 key medicinal plants, for instance
Atropa belladonna and Camptotheca acuminata, to the worldwide
research community for the advancement of drug production
and development2. Recently, we started the deep transcriptome
sequencing of Japanese medicinal plants and both cultivars of
L. angustifolius to obtainmore information about the enzymes and
1http://www.onekp.com/project.html
2http://medicinalplantgenomics.msu.edu/index.shtml
transcription factors involved in the productionof plant secondary
metabolites. Such publicly accessible databases will provide novel
information for the research community and ultimately accelerate
the progress of the study of plant science.
The predicted function or in vitro characterization of alkaloid
biosynthetic enzymes and other components must be conﬁrmed
in vivo (Ziegler and Facchini, 2008). However, there is no reli-
able and highly efﬁcient transformation protocol for Lupinus and
related plants. Virus induced gene silencing (VIGS), a technology
that exploits an RNA-mediated antiviral defense mechanism, is
a fast method for the generation of transient transformed plants
(Lu et al., 2003). VIGS has been used widely in plants for analysis
of gene function and has been adapted for high-throughput func-
tional genomics (Burch-Smith et al., 2004). Thus, VIGS might
be a powerful tool for assessing and characterizing the func-
tion of candidate genes in the QA biosynthetic pathway. Further
investigations on inter- and intracellular transport of pathway
intermediates and products and on cellular and subcellular local-
ization of enzymes are also important because they are crucial
factors in controlling the accumulation of target metabolites in
plants (Facchini et al., 2004).
CONCLUSION
Knowledge of the biosynthetic pathway of Lys-derived alkaloids is
limited. The best-studied pathway at the genetic level isQAbiosyn-
thesis; however, only two genes have been identiﬁed. Application
of current technologies, such as next-generation sequencing, high-
end proteomics, and metabolomics approaches, is needed to
study secondary metabolic pathways for a better understanding
of metabolic networks. Such information will aid in the develop-
ment of successful strategies in genetic engineering of secondary
metabolites in plants.
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